These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly. Kuthning A; Mösker E; Süssmuth RD Appl Microbiol Biotechnol; 2015 Aug; 99(15):6351-61. PubMed ID: 25846334 [TBL] [Abstract][Full Text] [Related]
5. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Caetano T; Krawczyk JM; Mösker E; Süssmuth RD; Mendo S Chem Biol; 2011 Jan; 18(1):90-100. PubMed ID: 21276942 [TBL] [Abstract][Full Text] [Related]
6. Rapid Screening of Lanthipeptide Analogs via In-Colony Removal of Leader Peptides in Escherichia coli. Si T; Tian Q; Min Y; Zhang L; Sweedler JV; van der Donk WA; Zhao H J Am Chem Soc; 2018 Sep; 140(38):11884-11888. PubMed ID: 30183279 [TBL] [Abstract][Full Text] [Related]
7. Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection. Caetano T; Krawczyk JM; Mösker E; Süssmuth RD; Mendo S Appl Environ Microbiol; 2011 Jul; 77(14):5023-6. PubMed ID: 21602391 [TBL] [Abstract][Full Text] [Related]
8. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide. Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127 [TBL] [Abstract][Full Text] [Related]
9. Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids. Oldach F; Al Toma R; Kuthning A; Caetano T; Mendo S; Budisa N; Süssmuth RD Angew Chem Int Ed Engl; 2012 Jan; 51(2):415-8. PubMed ID: 22128014 [TBL] [Abstract][Full Text] [Related]
10. A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Håvarstein LS; Diep DB; Nes IF Mol Microbiol; 1995 Apr; 16(2):229-40. PubMed ID: 7565085 [TBL] [Abstract][Full Text] [Related]
11. Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli. Nagao J; Harada Y; Shioya K; Aso Y; Zendo T; Nakayama J; Sonomoto K Biochem Biophys Res Commun; 2005 Oct; 336(2):507-13. PubMed ID: 16143300 [TBL] [Abstract][Full Text] [Related]
12. Class II two-peptide lanthipeptide proteases: exploring LicTP for biotechnological applications. Barbosa JC; Mösker E; Faria R; Süssmuth RD; Mendo S; Caetano T Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1687-1696. PubMed ID: 36763118 [TBL] [Abstract][Full Text] [Related]
13. Assessing the potential of the two-peptide lantibiotic lichenicidin as a new generation antimicrobial. Barbosa JC; Silva ÍC; Caetano T; Mösker E; Seidel M; Lourenço J; Süssmuth RD; Santos NC; Gonçalves S; Mendo S World J Microbiol Biotechnol; 2022 Jan; 38(1):18. PubMed ID: 34977979 [TBL] [Abstract][Full Text] [Related]
14. A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Sashihara T; Kimura H; Higuchi T; Adachi A; Matsusaki H; Sonomoto K; Ishizaki A Biosci Biotechnol Biochem; 2000 Nov; 64(11):2420-8. PubMed ID: 11193411 [TBL] [Abstract][Full Text] [Related]
15. The biology of lantibiotics from the lacticin 481 group is coming of age. Dufour A; Hindré T; Haras D; Le Pennec JP FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664 [TBL] [Abstract][Full Text] [Related]
16. Characterization of modification enzyme NukM and engineering of a novel thioether bridge in lantibiotic nukacin ISK-1. Shioya K; Harada Y; Nagao J; Nakayama J; Sonomoto K Appl Microbiol Biotechnol; 2010 Apr; 86(3):891-9. PubMed ID: 19915831 [TBL] [Abstract][Full Text] [Related]
17. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. McClerren AL; Cooper LE; Quan C; Thomas PM; Kelleher NL; van der Donk WA Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17243-8. PubMed ID: 17085596 [TBL] [Abstract][Full Text] [Related]
18. Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials. Montalbán-López M; van Heel AJ; Kuipers OP FEMS Microbiol Rev; 2017 Jan; 41(1):5-18. PubMed ID: 27591436 [TBL] [Abstract][Full Text] [Related]